Search company, investor...

Patient Communicator

patientcommunicator.com

Stage

Seed | Alive

Total Raised

$20K

Last Raised

$20K | 11 yrs ago

About Patient Communicator

Physician designed, cloud based communications and practice management platform for primary care practices.

Headquarters Location

United States

Missing: Patient Communicator's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Patient Communicator's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Research containing Patient Communicator

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Patient Communicator in 1 CB Insights research brief, most recently on Oct 12, 2022.

Patient Communicator Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Patient Communicator Rank

Patient Communicator Frequently Asked Questions (FAQ)

  • What is Patient Communicator's latest funding round?

    Patient Communicator's latest funding round is Seed.

  • How much did Patient Communicator raise?

    Patient Communicator raised a total of $20K.

  • Who are the investors of Patient Communicator?

    Investors of Patient Communicator include Blueprint Health.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.